Dow Up 0.51% Nasdaq Up 0.24%

Alexion Pharmaceuticals, Inc. (ALXN)

-NasdaqGS
191.02 Down 1.53(0.79%) Nov 21, 4:00PM EST
|After Hours : 191.02 0.00 (0.00%) Nov 21, 5:00PM EST
Prev Close:192.55
Open:195.87
Bid:N/A
Ask:194.82 x 100
1y Target Est:207.20
Beta:1.4
Earnings Date:Jan 28 - Feb 2 (Est.)
Day's Range:190.29 - 195.87
52wk Range:120.14 - 197.64
Volume:1,086,558
Avg Vol (3m):1,123,830
Market Cap:37.88B
P/E (ttm):79.46
EPS (ttm):2.40
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ALXN

Comparison

Symbol% ChgMkt Cap
ALXNDown 0.79%37.88B
AMGNUp 0.08%123.84B
BAXUp 0.63%39.26B

Key Statistics

Forward P/E (1 yr):32.27
P/S (ttm):18.39
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :5.20
Quarterly EPS Est (Dec-14) :1.29
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):1.23

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback